Regis Management CO LLC Glaukos Corp Transaction History

Regis Management CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$34.86 - $63.77 $174,300 - $318,850	-5,000 Closed	0 $0
Q3 2020 Oct 21, 2020	BUY	$37.23 - $50.97 $186,149 - $254,850	5,000 New	5,000 $247,000
Q1 2020 Apr 28, 2020	SELL	$25.53 - $70.14 $127,650 - $350,700	-5,000 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$38.13 - $68.37 $193,090 - $346,225	-5,064 Reduced 50.32%	5,000 $324,000
Q1 2017 May 08, 2018	BUY	N/A	10,064	10,064 $516,000

340

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.86B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Regis Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Regis Management CO LLC with notifications on news.